Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; CNS; central nervous system; CTCAE; Common Terminology Criteria for Adverse Events; EGFR; epidermal growth factor receptor; NCI; National Cancer Institute; NSCLC; non-small cell lung cancer; PRO; patient-reported outcome; PRO-CTCAE; Patient-Reported Outco
مقالات ISI معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; AMS; American medical systems; bPFS; biochemical progression-free survival; CTCAE; common terminology criteria for adverse events; DMFS; distant metastasis-free survival; DSS; disease specific survival; GI; gastrointestinal; GU; genitourinary; Gy; gray;
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; CR; complete response; CT; computed tomography; CTCAE; common terminology criteria for adverse events; CTV; clinical target volume; 3DCRT; conventional 3D conformal radiotherapy; EBRT; external body radiotherapy; Gy; gray; IMRT; intensity-modulated radiot
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; Paclitaxel hypersensitivity; Paclitaxel reaction; Paclitaxel allergy; Chemotherapy allergy; Chemotherapy hypersensitivity; Chemotherapy; Desensitization; Chemotherapy desensitization; CTCAE; Common Terminology Criteria for Adverse Events; HSR; Hypersensit
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; primary immunodeficiency; health status; transition to adulthood; CEREDIH; French Reference Center for PIDs; CTCAE; Common Terminology Criteria for Adverse Events; ENT; Ear, nose, and throat; F-CILC; French Childhood Immune Deficiency Long-Term Cohort; HR
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; AE; adverse event; ADR; adverse drug reaction; ANC; absolute neutrophil count; CI; confidence interval; CR; complete remission; CTCAE; common terminology criteria for adverse events; DEX; dexamethasone; ECOG; eastern cooperative oncology group; eCRF; elec
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; Hepatitis B virus (HBV); Hepatitis C virus (HCV); Breast cancer; Chemotherapy; HBV/HCV reactivation; Toxicity; HCV; hepatitis C virus; CHC; chronic hepatitis C; HBV; hepatitis B virus; CHB; chronic hepatitis B; DAAs; direct-acting antiviral agents; ER; es
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; Adverse drug reaction; High dose; Integrative oncology; Mistletoe; Viscum album L.; Safety; ADR; adverse drug reaction; CI; confidence interval; CTCAE; Common Terminology Criteria for Adverse Events; HRQL; health-related quality of life; ICD; Internationa
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; 3D-CRT; three-dimensional conformal radiation therapy; AP-PA; anteroposterior and posteroanterior fields; BMI; body mass index; CI; confidence interval; CTC-AE; Common Terminology Criteria for Adverse Events; DM; diabetes mellitus; EBRT; external beam rad
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; BIA; Bioimpedance; BMI; Body mass index; BMR; Basal metabolic rate; CRP; C-reactive protein; CT; Computerized tomography; CTCAE; Common Terminology Criteria for Adverse Events; ESPEN; European Society for Enteral and Parenteral Nutrition; FFM; Fat free ma
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; ALT; alanine aminotransferase; BCLC; Barcelona Clinic Liver Cancer; CTCAE; Common Terminology Criteria for Adverse Events; HCC; hepatocellular carcinoma; OR; odds ratio; PES; postembolization syndrome;
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; urinary bladder neoplasms; cystoscopy; aminolevulinic acid; photochemotherapy; drug-related side effects and adverse reactions; AE; adverse event; BLC; blue light cystoscopy; CIS; carcinoma in situ; CTCAE; Common Terminology Criteria for Adverse Events; F
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; ALK; anaplastic lymphoma receptor tyrosine kinase; ABCB1; ATP-binding cassette, sub-family B (MDR/TAP), member 1; APE1; apurinic/apyimidinic endonuclease 1; AKT; v-akt murine thymoma viral oncogene; BER; base excision repair; BRCA1; breast cancer 1; BRCA2
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; IMRT; intensity modulated radiotherapy; PCI; prophylactic cranial irradiation; WBRT; whole brain radiotherapy; SRS; stereotactic radiosurgery; SCLC; small-cell lung cancer; MRI; magnetic resonance imaging; CT; computed tomography; KPS; Karnofsky performan
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; Brain metastases; Gamma Knife; Gynecologic cancer; Ovarian cancer; Stereotactic radiosurgery; Uterus cancer; ADL; Activities of daily living; CTCAE; Common terminology criteria for adverse events; GKS; Gamma Knife surgery; KPS; Karnofsky Performance Statu
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; SBRT; stereotactic body radiation therapy; HCC; hepatocellular carcinoma; RECIST; response evaluation criteria in solid tumors; CTCAE; common terminology criteria for adverse events; LC; local control; OS; overall survival; PFS; progression-free survival;
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; Green tea; EGCG; Breast cancer; Postmenopausal; Adverse events; Hepatotoxicity; AE; adverse event; ALT; alanine aminotransferase; COMT; catechol-O-methyltransferase; CTCAE; Common Terminology Criteria for Adverse Events; EGCG; (-)- epigallocatechin-3-ga
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; CI; confidence interval; CTCAE; Common Terminology Criteria for Adverse Events;
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; ADE; Adverse drug event; CPOE; Computerized prescriber order entry; CTCAE; Common Terminology Criteria for Adverse Events; EHR; Electronic health record; NCC MERP; National Coordinating Council for Medication Error Reporting and Prevention; NICU; Neonatal
Imaging findings and complications of transcatheter interventional treatments via the inferior phrenic arteries in patients with hepatocellular carcinoma
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; IPA; inferior phrenic artery; HCC; hepatocellular carcinoma; TACE; transcatheter arterial chemoembolization; TAE; transcatheter arterial embolization; AG; angiography; CT-AG; CT during angiography; CT; computed tomography; CTCAE; Common Terminology Criter
Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BSA; body surface area; Ccr; creatinine clearance; CI; confidence interval; CR; complete response; CTCAE; common terminology criteria for adverse events; DCR;
Study Design and Rationale: A Multicenter, Prospective Trial of Electromagnetic Bronchoscopic and Electromagnetic Transthoracic Navigational Approaches for the Biopsy of Peripheral Pulmonary Nodules (ALL IN ONE Trial)
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; Electromagnetic navigation; Bronchoscopy; Pulmonary nodule; Transthoracic biopsy; ACCP; American College of Chest Physicians; AE; adverse event; ALL IN ONE; A Multicenter, Prospective Trial of Electromagnetic Bronchoscopic and Electromagnetic Transthoraci
Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: A retrospective analysis
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; L-AMB; liposomal amphotericin B; allo-HSCT; allogeneic hematopoietic stem cell transplantation; eGFR; estimated glomerular filtration rate; CTCAE; Common Terminology Criteria for Adverse Events; HR; hazard ratios; OR; odds ratio; FEK; fractional excretion
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; ACMG; American College of Medical Genetics and Genomics; ADHD RS-IV IA; Attention Deficit Hyperactivity Disorder Rating Scale IV inattention subscale; AE; adverse event; CTCAE; Common Terminology Criteria for Adverse Events; DMC; Data Monitoring Committee
Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; ACMG; American College of Medical Genetics and Genomics; ADHD RS-IV IA; Attention Deficit Hyperactivity Disorder Rating Scale IV, inattention subscore; AE; adverse event; ANCOVA; analysis of covariance; CANTAB; Cambridge Neuropsychological Test Automated
Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; PM; pharyngeal mucosa; PLR; penalized logistic regression; SVC; support vector classification; RFC; random forest classification; AUC; area under the receiver operating characteristic curve; NTCP; normal tissue complication probability; RT; radiotherapy;
Hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis: A single-center experience
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; IPF; idiopathic pulmonary fibrosis; AST; aspartate aminotransferase; ALT; alanine aminotransferase; CTCAE; Common Terminology Criteria for Adverse Events; ULN; upper limit of the normal range; BMI; body mass index; BSA; body surface area; FVC; forced vita
A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; PIKA adjuvant; Rabies vaccine; Immunogenicity; Safety; TLR3; Phase II; ACIP; Advisory Committee on Immunization Practices; AE; adverse event; CI; confidence interval; CIRB; Centralised Institutional Review Board; CSIRO; Commonwealth Scientific and Industr
The c-Abl inhibitor, nilotinib, as a potential therapeutic agent for chronic cerebellar ataxia
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; CA; cerebellar ataxia; PC; Purkinje cells; SCA; spinocerebellar ataxia; DRPLA; dentatorubral-pallidoluysian atrophy; MSA-C; multiple system atrophy-cerebellar type; MCP; middle cerebellar peduncles; CTCAE; Common Terminology Criteria for Adverse Events;
Original articleA phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; AE; adverse events; Afa; afatinib; AR; acquired resistance; AUC; area under curve; CR; complete response; CTCAE; Common Terminology Criteria for Adverse Events; CTP; clinical trial protocol; DLT; dose-limiting toxicity; ECOG; Eastern Cooperative Oncology
Physical health conditions and quality of life in adults with primary immunodeficiency diagnosed during childhood: AÂ French Reference Center for PIDs (CEREDIH) study
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; Primary immunodeficiency; childhood; young adults; health status; quality of life; CEREDIH; French Reference Center for PIDs; CTCAE; Common Terminology Criteria for Adverse Events; CVID; Common variable immunodeficiency; ENT; Ear, nose, and throat; F-CILC
Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; CTCAE; Common Terminology Criteria for Adverse Events; IRE; irreversible electroporation; LRFS; local recurrence-free survival; mRECIST; modified Response Evaluation Criteria In Solid Tumors;
Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: A randomized, open-label trial
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; doxycycline; erlotinib; folliculitis; non-small-cell lung cancer; rash; AE; adverse event; CI; confidence interval; CONSORT; CONsolidated Standards Of Reporting Trials; CTCAE; Common Terminology Criteria for Adverse Events; CYTAR; CYcline and TARceva; DI;
CommentaryMethods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; Patient-reported outcome; Symptom; Adverse event; Cancer; Toxicity; Common Terminology Criteria for Adverse Events;
Transcatheter CT Hepatic Arteriography-Guided Percutaneous Ablation to Treat Ablation Site Recurrences of Colorectal Liver Metastases: The Incomplete Ring Sign
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; CRLM; colorectal liver metastasis; CTCAE; Common Terminology Criteria for Adverse Events; FDG; fluorodeoxyglucose; IRE; irreversible electroporation; LSR; local site recurrence;
RTOG, CTCAE and WHO criteria for acute radiation dermatitis correlate with cutaneous blood flow measurements
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; Breast neoplasms; Radiotherapy; Radiodermatitis; Microcirculation; Skin pigmentation; Patient outcome assessment; RTOG; Radiation Therapy Oncology Group; CTCAE; Common Terminology Criteria for Adverse Events; WHO; World Health Organization;
Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung diseaseâ
â
â
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; ATS; American Thoracic Society; AUC; area under the curve; BAL; bronchoalveolar lavage; CTEAE; common terminology criteria for adverse events; CT; computed tomography; CFF; Cystic Fibrosis Foundation; CFQ-R; Cystic Fibrosis Questionnaire-Revised; CF TDN
Development and application of a comparative fatty acid analysis method to investigate voriconazole-induced hepatotoxicity
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; LPS; lipopolysaccharide; FAMEs; fatty acid methyl esters; T-Bil; total bilirubin; AST; aspartate aminotransferase; CTCAE; Common Terminology Criteria for Adverse Events; EIC; extracted ion chromatograms; TLR4; toll-like receptor 4; Comparative fatty acid
A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; AE; adverse event; CTCAE; common terminology criteria for adverse events; CI; confidence interval; DFS; disease-free survival; IHC; immunohistochemistry; i.v.; intravenous; MedDRA; medical dictionary for regulatory activities; NSCLC; Non-Small-Cell Lung C
Phase I study of the HER3-targeted antibody patritumab (U3-1287) combined with erlotinib in Japanese patients with non-small cell lung cancer
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; HER; human epidermal growth factor receptor; NSCLC; non-small cell lung cancer; DLT; dose-limiting toxicity; MTD; maximum tolerated dose; EGFR-TKI; epidermal growth factor receptor-tyrosine kinase inhibitor; RECIST; response evaluation criteria in solid t
Earlier and sustained response with incidental use of cardiovascular drugs among patients with low- to medium-grade meningiomas treated with radiosurgery (SRS) or stereotactic radiotherapy (SRT)
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; MRI; magnetic resonance imaging; RT; radiotherapy; SRS; stereotactic radiosurgery; SRT; stereotactic radiotherapy; Gy; Gray; OAR; organs at risk; GTV; gross tumor volume; PTV; planning target volume; RTOG; Radiation Therapy Oncology Group for stereotactic
Nouvel effet indésirable fréquent des inhibiteurs de la pompe à protons chez le sujet âgé : l'hyponatrémie modérée
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; hyponatrémie; sujet âgé; effet indésirable médicamenteux; inhibiteurs de la pompe à protons; tramadol; hyponatremia; elderly; adverse-drug-reaction; PPI; Tramadol; ADH; hormone anti-diurétique; AMM; autorisation de mise sur le marché; CTCAE; commo
Radiation-Induced Cholecystitis after Hepatic Radioembolization: Do We Need to Take Precautionary Measures?
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; CTCAE; Common Terminology Criteria for Adverse Events; LHA; left hepatic artery; MAA; macroaggregated albumin; RE; radioembolization; RHA; right hepatic artery; SPECT; single photon-emission computed tomography; VOI; volume of interest;
Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; 10; 10.4; CI; confidence interval; CT; computed tomography; CTCAE; Common Terminology Criteria for Adverse Events; ECOG; Eastern Cooperative Oncology Group; EVG; Elastic-Van Gieson; HR; hazard ratio; NSCLC; non-small cell lung cancer; OS; overall surviv
Trimodality Therapy for Superior Sulcus Non-Small Cell Lung Cancer: Southwest Oncology Group-Intergroup Trial S0220
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; ARDS; adult respiratory distress syndrome; BID; twice per day; CDDP; cisplatin; Chem Rx; chemotherapy; CI; confidence interval; csf; cerebrospinal fluid; CT; computed tomography; CTCAE; Common Terminology Criteria for Adverse Events; DFS; disease-free sur
Outcome and Toxicity for Patients Treated with Intensity Modulated Radiation Therapy for Localized Prostate Cancer
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; prostatic neoplasms; radiotherapy, intensity-modulated; toxicity; 3-D; 3-dimensional; ADT; androgen deprivation therapy; ASTRO; American Society for Therapeutic Radiology and Oncology; CT; computerized tomography; CTCAE; Common Terminology Criteria for Ad
Yttrium-90 Radioembolization for Intrahepatic Cholangiocarcinoma: Safety, Response, and Survival Analysis
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; CTCAE; Common Terminology Criteria for Adverse Events; EASL; European Association for the Study of the Liver; ECOG; Eastern Cooperative Oncology Group; ICC; intrahepatic cholangiocarcinoma; OS; overall survival; PS; performance status; RECIST; Response Ev
Research ArticleThe cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; HCV; hepatitis C virus; CsA; cyclosporin A; EC50; 50% effective concentration; HIV-1; Human Immunodeficiency Virus Type-1; PPIase; peptidyl prolyl isomerase; TEAE; treatment-emergent adverse event; CTCAE; Common Terminology Criteria for Adverse Events; IF
Percutaneous Cryoablation of Lung Tumors: Feasibility and Safety
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; CTCAE; Common Terminology Criteria for Adverse Events; RF; radiofrequency;
Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0
Keywords: معیارهای اصطلاحی مشترک برای رویدادهای نامطلوب; adverse events; cancer treatment; Common Terminology Criteria for Adverse Events; drug reactions; grading system; side effectsADL, activities of daily living; AE, adverse event; BSA, body surface area; CTCAE, Common Terminology Criteria for Adverse Events